Israel’s BiolineRx is buying UK’s Agalimmune,for $6 million. The private UK-based company has developed an innovative, anti-cancer immunotherapy platform. treatment that not only kills the tumor cells at the site of injection, but also brings about a durable, follow-on, anti-metastatic immune response.

http://www.globes.co.il/en/article-biolinerx-buys-uk-co-1001182333